Metraipolis › archive › dc_6569eb8c99da
Tildrakizumab in the Treatment of Complex and Severe Psoriasis: A Case Series — Europe PMC PMID:42652566
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42652566
- DOI
- 10.3390/jcm15166161
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T14:02:34.128Z
- SHA-256 of the archived text
40b85c40534d62fcd7bda65d5bb8087cfbdd0a94427110c45c28e9f92833186c- Stable URL of this page
https://metraipolis.com/documento/dc_6569eb8c99da
How to cite
Tildrakizumab in the Treatment of Complex and Severe Psoriasis: A Case Series — Europe PMC PMID:42652566 — Europe PMC (en), https://europepmc.org/article/MED/42652566 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6569eb8c99da (Metraipolis archive dc_6569eb8c99da, sha256 40b85c40534d62fcd7bda65d5bb8087cfbdd0a94427110c45c28e9f92833186c)
BibTeX
@misc{dc6569eb8c99da,
title = {Tildrakizumab in the Treatment of Complex and Severe Psoriasis: A Case Series — Europe PMC PMID:42652566},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42652566},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6569eb8c99da; sha256 40b85c40534d62fcd7bda65d5bb8087cfbdd0a94427110c45c28e9f92833186c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652566. Agents can read the archived copy with the MCP tool read_document.